MTL-004 (Gordian Pharma)

N/A

Report date: 2025/08/20 17:35:36
NME

Base Information

Drug NameMTL-004 (Gordian Pharma)
Drug Alias NameMTL-004
ClassificationSmall molecules
Mechanisms of ActionApoptosis inducers
TargetsUpdating
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGordian Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGordian Pharma Ltd
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A